Aethlon Medical Inc (AEMD) - Aggregate Business Assets

AEMD (Aethlon Medical Inc) - company brandmark

Aethlon Medical (AEMD) is mitigating regulatory risks by diversifying its focus between oncology and viral testing via the Hemopurifier system. This daily price chart for total assets is fixed at 5.77. The company currently lacks pricing power due to the current stage of clinical trials. Nevertheless, the brand is considered a pioneer in extracorporeal purification, maintaining significant weight in critical care medicine thanks to its life-saving filters.

AEMD (Aethlon) Company Total Assets history from 07/04/2022 to 10/30/2026

Financial and market metric breakdowns for Aethlon (AEMD)

- stock quotes and analyst forecast:
Share Price aethlonmedical.com|AEMD - Consensus Target
- market capitalization indicators:
Market Value Aethlon Medical Corp|AEMD - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share Aethlon Medical|AEMD - Book Capitalization|Market-to-Book Ratio aethlonmedical.com|AEMD - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Aethlon Medical|AEMD - Long-Term Debt to Capital|Short-Term Debt to Capital Aethlon Medical Corp|AEMD - Company Debts|Debts to Book Capitalization Ratio Aethlon Medical Corp|AEMD - Company Long-Term Debts|Short-Term Debt Aethlon Medical|Quick Ratio aethlonmedical.com
- net income and valuation multiples indicators:
AEMD - Net Income
Basic company analysis:aethlonmedical.com AEMD
Manufactured products of Aethlon

For high-quality stock selection, an investor must evaluate capital density via total assets, which are reverse-calculated here from the ROA to analyze financial stability. In the case of Aethlon Medical (AEMD), this metric reflects the resource base for developing an innovative hemopurifier that removes pathogens, allowing the company's gross assets to be used to forecast its ability to scale this unique blood purification technology.

Direct competitors

Total Business Assets DXCM|Cumulative Company Assets PEN|NOVT (Novanta Inc) - Aggregate Business Assets|Company Total Assets HAE|INSP (Inspire Medical Systems Inc) - Aggregate Asset Value|Company Total Assets PRCT (PROCEPT BioRobotics)|conmed.com (CNMD) - Company Assets|PLSE - Aggregate Company Assets|Aggregate Asset Value INMD (InMode Ltd)|PMI: Company Total Assets|Surmodics Inc. (SRDX) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc|neuropace.com - Total Asset Value of Company|Company Total Assets TCMD|SNWV - Company Assets|Outset - Cumulative Company Assets|Company Total Assets SmartVest ELMD|LNSR: Cumulative Company Assets|avitamedical.com - Aggregate Business Assets|PROF: Company Total Assets|BDMD - Company Total Asset Base|EDAP (EDAP TMS SA) - Company Total Assets|Cumulative Company Assets Bovie Medical (APYX)|Cumulative Company Assets ICCM (IceCure Medical Ltd)|LUNG (pulmonx.com) - Aggregate Asset Value|Aggregate Company Assets TELA Bio TELA|CTSO - Cumulative Company Assets|Sensus Healthcare Corp - Company Total Assets|Company Assets Zynex Corp|ECOR: Company Total Assets|Total Business Assets RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Company Total Assets|SeaStar Medical Holding Corporation (ICU) - Company Total Asset Base|Company Total Assets IRIX|Cumulative Company Assets ibs.inc INBS|Company Total Assets XAIR (Beyond Air)|Company Total Assets profusa.com PFSA|SSKN - Aggregate Company Assets|GCTK: Aggregate Company Assets|NAOV (NanoVibronix) - Cumulative Company Assets|Venus Concept Corporation - Aggregate Asset Value|NUWE (Nuwellis, Inc.) - Company Total Assets|Company Assets TransEnterix ASXC|Aggregate Company Assets Avinger (AVGR)|BioSig Technologies (BSGM) - Company Balance Sheet Assets|Cutera, Inc - Cumulative Company Assets|Company Total Assets Know Labs Corporation KNW|Inari Medical, Inc. - Company Total Assets|Company Total Asset Base nevro.com NVRO|reshapelifesciences.com (RSLS) - Aggregate Company Assets|Total Asset Value of Company SILK (Silk Road Medical, Inc.)